Zovirax | The Medical Letter Inc.

Matching articles for "Zovirax"

Antiviral Drugs for Varicella-Zoster Virus and Herpes Simplex Virus Infections

The Medical Letter on Drugs and Therapeutics • September 24, 2018; (Issue 1556)

The recommendations for treatment of varicella-zoster virus (VZV) and herpes simplex virus (HSV) infections are listed in tables 1 and 2. Vaccination against VZV was reviewed in a previous...

The recommendations for treatment of varicella-zoster virus (VZV) and herpes simplex virus (HSV) infections are listed in tables 1 and 2. Vaccination against VZV was reviewed in a previous issue.

Med Lett Drugs Ther. 2018 Sep 24;60(1556):153-7 | Show Full Introduction Hide Full Introduction

Drugs for Sexually Transmitted Infections

The Medical Letter on Drugs and Therapeutics • July 3, 2017; (Issue 1524)

The text and tables that follow include recommendations for management of sexually transmitted infections (STIs) other than HIV and viral hepatitis. Some of the indications and dosages recommended here have...

Med Lett Drugs Ther. 2017 Jul 3;59(1524):105-12 | Show Full Introduction Hide Full Introduction

Drugs for Sexually Transmitted Infections

The Medical Letter on Drugs and Therapeutics • September 1, 2013; (Issue 133)

Many infections can be transmitted during sexual contact. The text and tables that follow include recommendations for management of sexually transmitted infections (STIs) other than HIV, viral hepatitis, and enteric infections. Some of the indications and dosages recommended here have not been approved by the FDA.

Treat Guidel Med Lett. 2013 Sep;11(133):87-94 | Show Full Introduction Hide Full Introduction

Antiviral Drugs

The Medical Letter on Drugs and Therapeutics • March 1, 2013; (Issue 127)

The drugs of choice for treatment of viral infections (other than HIV) and their dosages are listed in Tables 1-6 on the pages that follow. Some of the indications and dosages recommended here have not been approved by the FDA. Vaccines used for the prevention of viral infections are discussed elsewhere.

Treat Guidel Med Lett. 2013 Mar;11(127):19-30 | Show Full Introduction Hide Full Introduction

Drugs for Non-HIV Viral Infections

The Medical Letter on Drugs and Therapeutics • October 1, 2010; (Issue 98)

The drugs of choice for treatment of non-HIV viral infections and their dosages are listed in Tables 1-6 on the pages that follow. Some of the indications and dosages recommended here have not been approved by the FDA. Vaccines used for the prevention of viral infections are discussed in another issue of Treatment Guidelines.

Treat Guidel Med Lett. 2010 Oct;8(98):71-82 | Show Full Introduction Hide Full Introduction

Drugs for Sexually Transmitted Infections

The Medical Letter on Drugs and Therapeutics • July 1, 2010; (Issue 95)

Many infections can be transmitted during sexual contact. The text and tables that follow are limited to management of sexually transmitted infections (STIs) other than HIV, viral hepatitis and enteric infections. The drugs of choice, their dosages and alternatives are listed in a table that begins on page 54. A table listing the adverse effects of some of these antimicrobials begins on page 58.

Treat Guidel Med Lett. 2010 Jul;8(95):53-60 | Show Full Introduction Hide Full Introduction

Drugs That May Cause Psychiatric Symptoms

The Medical Letter on Drugs and Therapeutics • December 15, 2008; (Issue 1301)

Many drugs can cause psychiatric symptoms, but a causal connection is often difficult to establish. Psychiatric symptoms that emerge during drug treatment could also be due to the underlying illness, previously unrecognized psychopathology, or psychosocial factors. The withdrawal of some drugs can cause symptoms such as anxiety, psychosis, delirium, agitation or depression.

Click here to view the free full article.

Med Lett Drugs Ther. 2008 Dec 15;50(1301):100-3 | Show Full Introduction Hide Full Introduction

Drugs for Sexually Transmitted Infections

The Medical Letter on Drugs and Therapeutics • September 1, 2007; (Issue 61)

Many infections can be transmitted during sexual contact. The text and tables that follow are limited to management of sexually transmitted infections (STIs) other than HIV, viral hepatitis and enteric infections. Guidelines are available from the US Centers for Disease Control and Prevention (CDC) with detailed recommendations for treatment of these diseases.

Treat Guidel Med Lett. 2007 Sep;5(61):81-9 | Show Full Introduction Hide Full Introduction

Drugs for Non-HIV Viral Infections

The Medical Letter on Drugs and Therapeutics • July 1, 2007; (Issue 59)

The drugs of choice for treatment of non-HIV viral infections with their dosages and cost are listed in Tables 1-6. Some of the indications and dosages recommended here have not been approved by the FDA. Vaccines used in the prevention of viral infections are discussed in the "Adult Immunization" issue of Treatment Guidelines.

Treat Guidel Med Lett. 2007 Jul;5(59):59-70 | Show Full Introduction Hide Full Introduction

Drugs for Non-HIV Viral Infections

The Medical Letter on Drugs and Therapeutics • April 1, 2005; (Issue 32)

The drugs of choice for non-HIV viral infections with their dosages and cost are listed in the tables that begin on page 24. Some of the indications and dosages recommended here have not been approved by the...

Treat Guidel Med Lett. 2005 Apr;3(32):23-32 | Show Full Introduction Hide Full Introduction

Drugs for Sexually Transmitted Infections

The Medical Letter on Drugs and Therapeutics • October 1, 2004; (Issue 26)

Many infections can be transmitted during sexual contact. The text and tables that follow are limited to management of sexually transmitted infections (STIs) other than HIV, viral hepatitis and enteric infections. Guidelines are available from the US Centers for Disease Control and Prevention (CDC) with detailed recommendations for treatment of these diseases (MMWR Recomm Rep 2002; 51, RR-6:1). New guidelines are expected soon.

Treat Guidel Med Lett. 2004 Oct;2(26):67-74 | Show Full Introduction Hide Full Introduction

Valacyclovir (Valtrex) for Oral Herpes

The Medical Letter on Drugs and Therapeutics • November 11, 2002; (Issue 1143)

Valacyclovir (Valtrex - GlaxoSmithKline) was recently approved by the FDA for one-day oral treatment of patients at least 12 years old with orolabial herpes simplex infections. The drug was previously approved...

Valacyclovir (Valtrex - GlaxoSmithKline) was recently approved by the FDA for one-day oral treatment of patients at least 12 years old with orolabial herpes simplex infections. The drug was previously approved for treatment and suppression of genital herpes and for treatment of herpes zoster (shingles).

Med Lett Drugs Ther. 2002 Nov 11;44(1143):95-6 | Show Full Introduction Hide Full Introduction

Drugs That May Cause Psychiatric Symptoms

The Medical Letter on Drugs and Therapeutics • July 8, 2002; (Issue 1134)

Many drugs can cause psychiatric symptoms, but a causal connection is often difficult to establish. Psychiatric symptoms that emerge during drug treatment may also be due to the underlying illness, previously unrecognized psychopathology, or psychosocial factors. The withdrawal of some drugs can cause symptoms such as anxiety, psychosis, delirium, agitation or depression.

Med Lett Drugs Ther. 2002 Jul 8;44(1134):59-62 | Show Full Introduction Hide Full Introduction

Drugs for Non-HIV Viral Infections

The Medical Letter on Drugs and Therapeutics • February 4, 2002; (Issue 1123)

The drugs of choice for non-HIV viral infections with their dosages and cost are listed in the table that begins on the next page. Since the last Medical Letter issue on this subject, some new drugs and some...

Med Lett Drugs Ther. 2002 Feb 4;44(1123):9-16 | Show Full Introduction Hide Full Introduction

Drugs that may cause Cognitive Disorders in the Elderly

The Medical Letter on Drugs and Therapeutics • November 27, 2000; (Issue 1093)

Older patients are especially susceptible to drug-induced cognitive impairment. They are more likely to be taking multiple drugs, to have higher blood levels of those drugs because of renal or hepatic dysfunction, and to have pre-existing cognitive problems that make it difficult to detect the role of drugs causing new symptoms or making old ones worse.

Med Lett Drugs Ther. 2000 Nov 27;42(1093):111-2 | Show Full Introduction Hide Full Introduction

Docosanol Cream (Abreva) for Recurrent Herpes Labialis

The Medical Letter on Drugs and Therapeutics • November 13, 2000; (Issue 1092)

Doconsanol 10% cream, a long-chain saturated alcohol, has been approved by the FDA for over-the-counter treatment of herpes...

Doconsanol 10% cream, a long-chain saturated alcohol, has been approved by the FDA for over-the-counter treatment of herpes labialis.

Med Lett Drugs Ther. 2000 Nov 13;42(1092):108 | Show Full Introduction Hide Full Introduction

Drugs for Non-HIV Viral Infections

The Medical Letter on Drugs and Therapeutics • December 3, 1999; (Issue 1067)

The drugs of choice for non-HIV viral infections with their dosages and cost are listed in the [article's]...

The drugs of choice for non-HIV viral infections with their dosages and cost are listed in the [article's] table.

Med Lett Drugs Ther. 1999 Dec 3;41(1067):113-20 | Show Full Introduction Hide Full Introduction

Drugs for Sexually Transmitted Infections

The Medical Letter on Drugs and Therapeutics • September 24, 1999; (Issue 1062)

Many infections can be transmitted during sexual contact. The text and tables [in this article] are limited to treatment of non-HIV infections associated primarily with sexual...

Many infections can be transmitted during sexual contact. The text and tables [in this article] are limited to treatment of non-HIV infections associated primarily with sexual transmission.

Med Lett Drugs Ther. 1999 Sep 24;41(1062):85-90 | Show Full Introduction Hide Full Introduction

Drugs for Non-HIV Viral Infections

The Medical Letter on Drugs and Therapeutics • August 1, 1997; (Issue 1006)

The drugs of choice for non-HIV viral infections with their dosages and cost are listed in the table on the next page. The treatment of HIV infection will be discussed in a future...

The drugs of choice for non-HIV viral infections with their dosages and cost are listed in the table on the next page. The treatment of HIV infection will be discussed in a future issue.

Med Lett Drugs Ther. 1997 Aug 1;39(1006):69-76 | Show Full Introduction Hide Full Introduction

Valacyclovir

The Medical Letter on Drugs and Therapeutics • January 5, 1996; (Issue 965)

Valacyclovir (Valtrex - Glaxo Wellcome), an L- valyl ester of acyclovir (Zovirax), has been approved by the US Food and Drug Administration (FDA) for oral treatment of herpes zoster (shingles) in...

Valacyclovir (Valtrex - Glaxo Wellcome), an L- valyl ester of acyclovir (Zovirax), has been approved by the US Food and Drug Administration (FDA) for oral treatment of herpes zoster (shingles) in immunocompetent adults. Famciclovir (Famvir - Medical Letter, 36:97, 1994) is also available for this indication.

Med Lett Drugs Ther. 1996 Jan 5;38(965):3-4 | Show Full Introduction Hide Full Introduction

Famciclovir for Herpes Zoster

The Medical Letter on Drugs and Therapeutics • October 28, 1994; (Issue 934)

Famciclovir (Famvir - SmithKline Beecham) is now available in the USA for oral treatment of acute uncomplicated herpes zoster (shingles). The manufacturer claims that use of the drug reduces the duration of...

Famciclovir (Famvir - SmithKline Beecham) is now available in the USA for oral treatment of acute uncomplicated herpes zoster (shingles). The manufacturer claims that use of the drug reduces the duration of postherpetic neuralgia. Famciclovir is similar to acyclovir (Zovirax - Burroughs Wellcome), which has been the drug of choice for treatment of varicella-zoster and herpes simplex virus infections (Medical Letter, 36:27, 1994).

Med Lett Drugs Ther. 1994 Oct 28;36(934):97-8 | Show Full Introduction Hide Full Introduction

Drugs for AIDS and Associated infections

The Medical Letter on Drugs and Therapeutics • September 3, 1993; (Issue 904)

Results of recently completed clinical trials have led to some changes in recommendations for treatment of human immunodeficiency virus (HIV) and other infections associted with...

Results of recently completed clinical trials have led to some changes in recommendations for treatment of human immunodeficiency virus (HIV) and other infections associted with AIDS.

Med Lett Drugs Ther. 1993 Sep 3;35(904):79-86 | Show Full Introduction Hide Full Introduction

Drugs for Viral Infections

The Medical Letter on Drugs and Therapeutics • April 3, 1992; (Issue 867)

Since the last review of this topic (Medical Letter, 32:73, August 10, 1990) some new antiviral agents have been approved and the indications for several others expanded. The drugs of choice for viral...

Med Lett Drugs Ther. 1992 Apr 3;34(867):31-6 | Show Full Introduction Hide Full Introduction

Foscarnet

The Medical Letter on Drugs and Therapeutics • January 10, 1992; (Issue 861)

Phosphonoformic acid or foscarnet (Foscavir - Astra), a synthetic antiviral drug, has now been approved by the US Food and Drug Administration for intravenous (IV) treatment of cytomegalovirus (CMV) retinitis...

Phosphonoformic acid or foscarnet (Foscavir - Astra), a synthetic antiviral drug, has now been approved by the US Food and Drug Administration for intravenous (IV) treatment of cytomegalovirus (CMV) retinitis in patients with AIDS. CMV retinitis occurs in up to 30% of patients with AIDS and often causes blindness (MD de Smet and RB Nussenbatt, JAMA, 266:3019, Dec 4, 1991).

Med Lett Drugs Ther. 1992 Jan 10;34(861):3-4 | Show Full Introduction Hide Full Introduction

Drugs for Viral Infections

The Medical Letter on Drugs and Therapeutics • August 10, 1990; (Issue 824)

...

Med Lett Drugs Ther. 1990 Aug 10;32(824):73-8 | Show Full Introduction Hide Full Introduction